Mechanistic and functional characterization of a novel microglia-specific PLCG2 p.P522R variant in aging and Alzheimer's disease-related cellular processes

Description of the granted funding

This research project elucidates how recently identified variant in microglia-specific PLCG2 gene (P522R, protective variant) is associated with molecular, cellular, pathophysiological and behavioral aspects of aging and Alzheimer's disease (AD). State-of-the-art in vitro and in vivo models and techniques in combination with up-to-date methodologies will be used to facilitate mechanistic characterization of the variant. It is expected that untangling the protective action(s) exerted by the variant will shed light into the role of microglia and immune system upon aging and AD-associated cellular stress. Furthermore, it is expected that the project pinpoints new therapeutic targets and paves the way for potential treatment strategies, which are based on PLC?2-related modulation of microglia in AD and in other neurodegenerative diseases involving altered immune system function.
Show more

Starting year

2020

End year

2023

Granted funding

mari takalo
262 004 €

Mari Takalo Orcid -palvelun logo
262 004 €

Role in consortium of the Academy of Finland

Leader

Funder

Research Council of Finland

Funding instrument

Postdoctoral Researcher

Other information

Funding decision number

330178

Fields of science

Biomedicine

Research fields

Biolääketieteet

Identified topics

brain, neuroscience